2022 Annual Meeting Virtual Experience | S3 - Abstracts of Distinction 3
Program Materials Program Evaluations
| 02:30 PM - 02:38 PM EDT | Speaker |
Fast Progression in Amyotrophic Lateral Sclerosis: Pathways and Biomarkers from Multi-Omics Analysis
Roland G. Huber, PhD |
| 02:38 PM - 02:46 PM EDT | Speaker |
Autonomic dysfunction following COVID-19 infection: an early experience
Kamal Shouman, MD |
| 02:46 PM - 02:54 PM EDT | Speaker |
Meta-analysis of 175 Patients with COVID-19 and Seizures, Status Epilepticus, or Cortical Myoclonus: An Individual Patient Data Analysis
Cristina Jageka, MD |
| 02:54 PM - 03:00 PM EDT | Q&A |
Q&A
Cristina Jageka, MD, Roland G. Huber, PhD, Kamal Shouman, MD |
| 03:00 PM - 03:08 PM EDT | Speaker |
Socioeconomic Status and Cognitive Function in Children with HIV: Evidence from the HIV-Associated Neurocognitive Disorders in Zambia (HANDZ) Study
Esau G. Mbewe |
| 03:08 PM - 03:16 PM EDT | Speaker |
Clinical Characteristics and Outcomes of Neuroinvasive West Nile Virus Infection in Immunosuppressed and Immunocompetent Individuals Treated at the Mayo Clinic Hospitals
David Gritsch, MD, PhD |
| 03:16 PM - 03:24 PM EDT | Speaker |
Durability of 10-kHz Spinal Cord Stimulation for Painful Diabetic Neuropathy: 18-Month Multicenter Randomized Controlled Trial Results
Erika Petersen, MD |
| 03:24 PM - 03:30 PM EDT | Q&A |
Q&A
Esau G. Mbewe, Erika Petersen, MD, David Gritsch, MD, PhD |
| Thomas Wychowski, MD | Dr. Wychowski has nothing to disclose. |
| Stefano Sandrone, PhD | Dr. Sandrone has nothing to disclose. |
| David Gritsch, MD, PhD | Dr. Gritsch has nothing to disclose. |
| Kamal Shouman, MD | Dr. Shouman has nothing to disclose. |
| Erika Petersen, MD | Erika Petersen, MD has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Nevro. Erika Petersen, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbott Neuromodulation. Erika Petersen, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Erika Petersen, MD has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Vertos. Erika Petersen, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Saluda. Erika Petersen, MD has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for American Society of Pain and Neurosciences. Erika Petersen, MD has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for SynerFuse. Erika Petersen, MD has stock in SynerFuse. Erika Petersen, MD has stock in neuro.42. The institution of Erika Petersen, MD has received research support from Saluda. The institution of Erika Petersen, MD has received research support from Nevro. The institution of Erika Petersen, MD has received research support from ReNeuron. The institution of Erika Petersen, MD has received research support from Neuros. Erika Petersen, MD has received intellectual property interests from a discovery or technology relating to health care. |
| Esau G. Mbewe | Esau G. Mbewe has received research support from Research was supported by the National Institute Of Neurological Disorders And Stroke of the National Institutes of Health under Award Number K23NS117310. . |
| Cristina Jageka, MD | Miss Jageka has nothing to disclose. |
| Roland G. Huber, PhD | Dr. Huber has received intellectual property interests from a discovery or technology relating to health care. |